Lampire Biological Labs — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Lampire Biological Labs is a long-established, privately-held provider of critical biological reagents and custom development services. Its business model is primarily service-based, complemented by product sales, focusing on antibody characterization, raw biological materials, and contract manufacturing. With over 170 employees, a 600-acre facility, and a diverse animal colony, Lampire supports global research and diagnostic development. The company is revenue-generating, leveraging decades of experience to offer customized, high-quality solutions to its clients.

Antibodies

Technology Platform

Integrated platform for custom antibody development (polyclonal/monoclonal), advanced characterization (kinetics, epitope binning), biological raw material sourcing from on-site animal colony, and manufacturing of secondary antibodies, purified proteins (BSA, IgGs), and cell culture products.

Opportunities

Growing demand for biologics and diagnostics drives need for high-quality antibody discovery and characterization services.

The trend toward outsourcing by pharma and biotech firms benefits established CROs/CDMOs like Lampire.

Its unique, integrated model from animal source to finished product offers a competitive advantage in traceability and customization.

Risk Factors

Operational risks associated with maintaining a large live-animal colony, including disease and regulatory welfare compliance.

High competition in the life science tools market from larger players and technological shifts.

Potential revenue volatility from reliance on custom project work and key clients.

Competitive Landscape

Lampire competes in the fragmented life science tools and services market, facing competition from large reagent distributors (e.g., Thermo Fisher, Abcam), specialized antibody developers, and other contract research organizations. Its differentiation lies in its vertical integration, control over biological sourcing, high degree of customization, and specific accreditations (ISO 13485, AAALAC) for serving diagnostic and regulated markets.

More companies in Biologics / Biosimilars →More companies in United States →